Market Cap 72.96B
Revenue (ttm) 177.01B
Net Income (ttm) 5.98B
EPS (ttm) N/A
PE Ratio 10.68
Forward PE 10.92
Profit Margin 3.38%
Debt to Equity Ratio 0.72
Volume 1,392,800
Avg Vol 1,842,292
Day's Range N/A - N/A
Shares Out 222.24M
Stochastic %K 79%
Beta 0.60
Analysts Strong Sell
Price Target $379.63

Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 833 401 1577
Address:
220 Virginia Avenue, Indianapolis, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:08 AM
$ELV: The last close at $325.83 indicates a bearish sentiment, as the price is below both the 30-day MA of $336.85 and the 50-day MA of $329.73. The RSI at 39.86 suggests the stock is nearing oversold territory, which could indicate a potential reversal point, but currently reflects weakness. The price is also closer to the 60-day low of $300.81 than the high of $364.87, reinforcing a bearish bias. Suggested entry: $325.00, with a stop loss at $300.00 to limit potential losses. Target 1 could be set at $335.00, aligning with the 30-day MA, while Target 2 could be at $345.00, providing a reasonable upside based on recent price action. Overall, the trade plan anticipates a short-term rebound due to oversold conditions while acknowledging the prevailing bearish trend. https://privateprofiteers.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 15 at 5:11 AM
Enter: $ELV Calls Strike Price: $330 Expiry Date: DEC 19 2025 Buy in Price: $11.40 - $12.60 Sell Price: $16.30 Profit : +43% (Turn every $1 into $1.43) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:29 PM
$ELV is currently trading at $325.83, showing a bearish market context as it is below both the 30-day moving average (MA30) of $336.85 and the 50-day moving average (MA50) of $329.73. The RSI at 39.86 indicates that the stock is nearing oversold territory, suggesting potential for a reversal or bounce. However, the stock remains within the 60-day high of $364.87 and low of $300.81, indicating a range-bound environment. Suggested entry point is around $325, with a stop loss set at $315 to limit potential losses. Target 1 is set at $335, aligning with the MA30, while Target 2 is at $350, providing a favorable risk-reward ratio. Monitor price action closely for any signs of strength or weakness as it approaches these levels. For further insights and strategies, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
FallingKnifeVictim
FallingKnifeVictim Nov. 14 at 3:44 PM
$ELV risk back on for now, watch out!
0 · Reply
Stocktwits1987
Stocktwits1987 Nov. 14 at 1:56 PM
$OSCR welcomes new bag holders. it's gonna fall futher. If i would have owned $OSCR shares i would dump them immediatelyand buy better P/E stocks like $CI and $ELV
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 14 at 12:32 PM
Enter: $ELV Calls Strike Price: $330 Expiry Date: DEC 19 2025 Buy in Price: $14.20 - $14.20 Sell Price: $31.24 Profit : +120% (Turn every $1 into $2.20) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:39 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $ARGX $TU $HLN $ELV
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:03 AM
$ELV trade plan: Market context shows a recent close at $328.28, with an RSI of 41.19 indicating a neutral to slightly bearish momentum. The current price is below both the 30-day MA of $337.67 and the 50-day MA of $329.49, suggesting a bearish trend in the short to medium term. The 60-day high of $364.87 and low of $300.81 indicates a range-bound market, with potential resistance at the high and support near the low. Directional bias leans bearish given the price's position relative to the MAs and the RSI's proximity to oversold conditions. Suggested entry: $325.00 (below current close). Stop: $320.00 (to limit losses). Targets: $340.00 (first target near the 30-day MA) and $350.00 (second target closer to the 60-day high). Monitor for potential reversal signals if price approaches support levels. https://privateprofiteers.com
0 · Reply
_SquidGains_
_SquidGains_ Nov. 14 at 12:13 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 13 at 7:22 AM
Enter: $ELV Calls Strike Price: $340 Expiry Date: DEC 19 2025 Buy in Price: $10.60 - $10.90 Sell Price: $15.69 Profit : +48% (Turn every $1 into $1.48) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Latest News on ELV
First Eagle U.S. Fund Q3 2025 Portfolio Review

Nov 9, 2025, 2:01 PM EST - 6 days ago

First Eagle U.S. Fund Q3 2025 Portfolio Review

CMCSA CRM GOOG ORCL PM GOOGL


Columbia Balanced Fund Q3 2025 Portfolio Update

Nov 4, 2025, 2:30 AM EST - 11 days ago

Columbia Balanced Fund Q3 2025 Portfolio Update

EA EBAY INTU TEL VRTX


Artisan Global Value Fund Q3 2025 Portfolio Update

Oct 30, 2025, 12:30 AM EDT - 16 days ago

Artisan Global Value Fund Q3 2025 Portfolio Update

BK GOOG GOOGL PGR


Elevance Health: Q3 Figures Underscore Slow But Steady Recovery

Oct 24, 2025, 3:29 AM EDT - 22 days ago

Elevance Health: Q3 Figures Underscore Slow But Steady Recovery


Elevance: Checking Out The Q3 Report

Oct 22, 2025, 7:12 AM EDT - 24 days ago

Elevance: Checking Out The Q3 Report


Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 11:54 AM EDT - 25 days ago

Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript


Elevance Health Quarterly Profit Climbs as Memberships Slip

Oct 21, 2025, 7:27 AM EDT - 25 days ago

Elevance Health Quarterly Profit Climbs as Memberships Slip


Elevance Health Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 25 days ago

Elevance Health Reports Third Quarter 2025 Results


Top 15 High-Growth Dividend Stocks For September 2025

Sep 1, 2025, 6:16 AM EDT - 2 months ago

Top 15 High-Growth Dividend Stocks For September 2025

ACN APH BAC BK DKS DPZ GPN


Elevance Health - Piggy Bank Or Headache?

Aug 21, 2025, 5:46 PM EDT - 3 months ago

Elevance Health - Piggy Bank Or Headache?


Elevance Health loses bid to challenge US Medicare star ratings

Aug 19, 2025, 12:49 PM EDT - 3 months ago

Elevance Health loses bid to challenge US Medicare star ratings


3 SWANs On Sale

Aug 8, 2025, 7:00 AM EDT - 3 months ago

3 SWANs On Sale

BMY REXR


Elevance Health: CEO Buys As CareBridge Drives Strong Growth

Jul 24, 2025, 12:16 PM EDT - 4 months ago

Elevance Health: CEO Buys As CareBridge Drives Strong Growth


Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More

Jul 17, 2025, 1:25 PM EDT - 4 months ago

Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More

CSX PEP


Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript

Jul 17, 2025, 11:23 AM EDT - 4 months ago

Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript


Elevance cuts annual profit forecast on high medical costs

Jul 17, 2025, 6:12 AM EDT - 4 months ago

Elevance cuts annual profit forecast on high medical costs


Elevance Health Reports Second Quarter 2025 Results

Jul 17, 2025, 6:00 AM EDT - 4 months ago

Elevance Health Reports Second Quarter 2025 Results


Elevance Health: Much Cheaper Than UNH, Yet No Drama

Jul 16, 2025, 2:19 PM EDT - 4 months ago

Elevance Health: Much Cheaper Than UNH, Yet No Drama


PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:08 AM
$ELV: The last close at $325.83 indicates a bearish sentiment, as the price is below both the 30-day MA of $336.85 and the 50-day MA of $329.73. The RSI at 39.86 suggests the stock is nearing oversold territory, which could indicate a potential reversal point, but currently reflects weakness. The price is also closer to the 60-day low of $300.81 than the high of $364.87, reinforcing a bearish bias. Suggested entry: $325.00, with a stop loss at $300.00 to limit potential losses. Target 1 could be set at $335.00, aligning with the 30-day MA, while Target 2 could be at $345.00, providing a reasonable upside based on recent price action. Overall, the trade plan anticipates a short-term rebound due to oversold conditions while acknowledging the prevailing bearish trend. https://privateprofiteers.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 15 at 5:11 AM
Enter: $ELV Calls Strike Price: $330 Expiry Date: DEC 19 2025 Buy in Price: $11.40 - $12.60 Sell Price: $16.30 Profit : +43% (Turn every $1 into $1.43) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:29 PM
$ELV is currently trading at $325.83, showing a bearish market context as it is below both the 30-day moving average (MA30) of $336.85 and the 50-day moving average (MA50) of $329.73. The RSI at 39.86 indicates that the stock is nearing oversold territory, suggesting potential for a reversal or bounce. However, the stock remains within the 60-day high of $364.87 and low of $300.81, indicating a range-bound environment. Suggested entry point is around $325, with a stop loss set at $315 to limit potential losses. Target 1 is set at $335, aligning with the MA30, while Target 2 is at $350, providing a favorable risk-reward ratio. Monitor price action closely for any signs of strength or weakness as it approaches these levels. For further insights and strategies, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
FallingKnifeVictim
FallingKnifeVictim Nov. 14 at 3:44 PM
$ELV risk back on for now, watch out!
0 · Reply
Stocktwits1987
Stocktwits1987 Nov. 14 at 1:56 PM
$OSCR welcomes new bag holders. it's gonna fall futher. If i would have owned $OSCR shares i would dump them immediatelyand buy better P/E stocks like $CI and $ELV
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 14 at 12:32 PM
Enter: $ELV Calls Strike Price: $330 Expiry Date: DEC 19 2025 Buy in Price: $14.20 - $14.20 Sell Price: $31.24 Profit : +120% (Turn every $1 into $2.20) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:39 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $ARGX $TU $HLN $ELV
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:03 AM
$ELV trade plan: Market context shows a recent close at $328.28, with an RSI of 41.19 indicating a neutral to slightly bearish momentum. The current price is below both the 30-day MA of $337.67 and the 50-day MA of $329.49, suggesting a bearish trend in the short to medium term. The 60-day high of $364.87 and low of $300.81 indicates a range-bound market, with potential resistance at the high and support near the low. Directional bias leans bearish given the price's position relative to the MAs and the RSI's proximity to oversold conditions. Suggested entry: $325.00 (below current close). Stop: $320.00 (to limit losses). Targets: $340.00 (first target near the 30-day MA) and $350.00 (second target closer to the 60-day high). Monitor for potential reversal signals if price approaches support levels. https://privateprofiteers.com
0 · Reply
_SquidGains_
_SquidGains_ Nov. 14 at 12:13 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 13 at 7:22 AM
Enter: $ELV Calls Strike Price: $340 Expiry Date: DEC 19 2025 Buy in Price: $10.60 - $10.90 Sell Price: $15.69 Profit : +48% (Turn every $1 into $1.48) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Gertjan13
Gertjan13 Nov. 13 at 5:57 AM
$ELV next week $350-$365!
0 · Reply
jdlman
jdlman Nov. 13 at 5:13 AM
$ELV lets continue the trend .k
0 · Reply
FallingKnifeVictim
FallingKnifeVictim Nov. 13 at 4:07 AM
$ELV given Trump’s sentiments related tonight at the bill signing, it’s gonna be uphill sledding to get him to sign an ACA subsidy extension in December if at all (eg, January, when govt will shut down again). I fear that’s going to put a ceiling on the affected insurers, even if it’s not that substantial. Or maybe that’s already priced in, not sure.
1 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:09 AM
$ELV is currently at $316.23, showing a bearish market context with an RSI of 30.09, indicating oversold conditions. The price is below both the 30-day MA of 338.27 and the 50-day MA of 328.98, reinforcing a downward trend. The recent 60-day high of 364.87 and low of 300.81 suggests a range-bound market, with the potential for a bounce from the lower end. Directional bias is bearish, but with the RSI indicating oversold conditions, a short-term reversal may be possible. Suggested entry is at $310, just above the 60D low, with a stop loss at $300 to limit downside risk. Targets are set at $325 (near the 50-day MA) and $340 (near the 30-day MA), allowing for a recovery towards the moving averages. Monitor for volume spikes and any signs of reversal to validate the trade. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
lee305
lee305 Nov. 12 at 8:08 PM
$ELV $UNH so we have an increasingly likely scenario where millions drop out of ACA.. but what then? Well… 1) I think when reality starts hits and kids with cancer and no insurance bankrupt families, the issue will be front and center for the next couple elections cycles until subsidies of some form are restored. 2) Private insurance premiums will go up to cover most of the cost of uninsured/non-payers. Hospitals don’t make money as it is and they certainly can’t eat the costs. 3) will be more pressure on private employers to provide better healthcare options.
2 · Reply
Ro_Patel
Ro_Patel Nov. 12 at 6:00 PM
House Democratic leaders to propose a 3-year extension of the soon-to-expire Affordable Care Act (ACA or commonly referred as ObamaCare) to subsidies at the center of the govt shutdown fight. The amendment is all but guaranteed to fail, given the Republican majority on the Rules panel & the GOP’s long-standing opposition to the ACA, which they’ve sought to repeal since its creation 15 years ago. But the push is designed to put Republican lawmakers on record opposing an extension of the enhanced ACA tax credits, which benefit more than 20M Americans of all political affiliations around the country but most (57%) from Republican districts However, there are a few Repulicans who are crumbling Those patients are facing huge spikes in premiums & other out-of-pocket health care costs if Congress doesn’t intervene before Jan 1. --- Game is still not over What if they changed the name to TrumpCare instead??? $UNH $ELV $CNC $HCA $XLV
3 · Reply
senseidragon
senseidragon Nov. 12 at 3:09 PM
$CNC $ELV $HUM $LLY $UNH give me 350 today
0 · Reply
senseidragon
senseidragon Nov. 12 at 2:49 PM
Looks like healthcare is back innsession $UNH $LLY $ELV $CNC $HUM
0 · Reply
Estimize
Estimize Nov. 12 at 12:09 PM
Wall St is expecting 3.17 EPS for $ELV Q4 [Reporting 01/28 BMO] http://www.estimize.com/intro/elv?chart=historical&metric_name=eps&utm_cont
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 12 at 6:55 AM
Enter: $ELV Calls Strike Price: $320 Expiry Date: DEC 19 2025 Buy in Price: $11.00 - $11.70 Sell Price: $23.21 Profit : +111% (Turn every $1 into $2.11) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:45 AM
$ELV is currently at $316.23, showing a bearish market context with an RSI of 30.09, indicating oversold conditions. The price is below both the 30-day MA of 338.27 and the 50-day MA of 328.98, reinforcing a downward trend. The recent 60-day high of 364.87 and low of 300.81 suggests a range-bound market, with the potential for a bounce from the lower end. Directional bias is bearish, but with the RSI indicating oversold conditions, a short-term reversal may be possible. Suggested entry is at $310, just above the 60D low, with a stop loss at $300 to limit downside risk. Targets are set at $325 (near the 50-day MA) and $340 (near the 30-day MA), allowing for a recovery towards the moving averages. Monitor for volume spikes and any signs of reversal to validate the trade. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
HoggMcCrankin
HoggMcCrankin Nov. 11 at 8:22 PM
$ELV $UNH $XLV why are subsidies so crucial? Oh that’s right, because Obamacare has always been AIDS and too expensive
1 · Reply